Trial Profile
Phase II study of pre-operative chemotherapy with Taxol, cisplatin, and 5-fluorouracil followed by G-CSF in patients with resectable local-regional carcinoma of esophagus
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Cisplatin; Fluorouracil
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 14 Nov 2006 Status change
- 29 Oct 2005 New trial record.